Literature DB >> 18613225

Incorporating validation subsets into discrete proportional hazards models for mismeasured outcomes.

Amalia S Magaret1.   

Abstract

Standard proportional hazards methods are inappropriate for mismeasured outcomes. Previous work has shown that outcome mismeasurement can bias estimation of hazard ratios for covariates. We previously developed an adjusted proportional hazards method that can produce accurate hazard ratio estimates when outcome measurement is either non-sensitive or non-specific. That method requires that mismeasurement rates (the sensitivity and specificity of the diagnostic test) are known. Here, we develop an approach to handle unknown mismeasurement rates. We consider the case where the true failure status is known for a subset of subjects (the validation set) until the time of observed failure or censoring. Five methods of handling these mismeasured outcomes are described and compared. The first method uses only subjects on whom complete data are available (validation subset), whereas the second method uses only mismeasured outcomes (naive method). Three other methods include available data from both validated and non-validated subjects. Through simulation, we show that inclusion of the non-validated subjects can improve efficiency relative to use of the complete case data only and that inclusion of some true outcomes (the validation subset) can reduce bias relative to use of mismeasured outcomes only. We also compare the performance of the validation methods proposed using an example data set.

Entities:  

Mesh:

Year:  2008        PMID: 18613225      PMCID: PMC2574985          DOI: 10.1002/sim.3365

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

1.  Using validation sets for outcomes and exposure to infection in vaccine field studies.

Authors:  M E Halloran; I M Longini
Journal:  Am J Epidemiol       Date:  2001-09-01       Impact factor: 4.897

2.  Augmented inverse probability weighted estimator for Cox missing covariate regression.

Authors:  C Y Wang; H Y Chen
Journal:  Biometrics       Date:  2001-06       Impact factor: 2.571

3.  Product limit estimation for infectious disease data when the diagnostic test for the outcome is measured with uncertainty.

Authors:  B A Richardson; J P Hughes
Journal:  Biostatistics       Date:  2000-09       Impact factor: 5.899

4.  On estimation of vaccine efficacy using validation samples with selection bias.

Authors:  Daniel O Scharfstein; M Elizabeth Halloran; Haitao Chu; Michael J Daniels
Journal:  Biostatistics       Date:  2006-03-23       Impact factor: 5.899

5.  Sensitivity and specificity of standard and rapid HIV-antibody tests evaluated by seroconversion and non-seroconversion low-titre panels.

Authors:  E Kuun; M Brashaw; A D Heyns
Journal:  Vox Sang       Date:  1997       Impact factor: 2.144

6.  Bias due to misclassification in the estimation of relative risk.

Authors:  K T Copeland; H Checkoway; A J McMichael; R H Holbrook
Journal:  Am J Epidemiol       Date:  1977-05       Impact factor: 4.897

7.  Use of predictive value to adjust relative risk estimates biased by misclassification of outcome status.

Authors:  M S Green
Journal:  Am J Epidemiol       Date:  1983-01       Impact factor: 4.897

8.  Modelling the cumulative risk for a false-positive under repeated screening events.

Authors:  A E Gelfand; F Wang
Journal:  Stat Med       Date:  2000-07-30       Impact factor: 2.373

9.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.

Authors:  H L Martin; P M Nyange; B A Richardson; L Lavreys; K Mandaliya; D J Jackson; J O Ndinya-Achola; J Kreiss
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

10.  Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.

Authors:  J M Lachin; M A Foulkes
Journal:  Biometrics       Date:  1986-09       Impact factor: 2.571

View more
  12 in total

1.  A pathway EM-algorithm for estimating vaccine efficacy with a non-monotone validation set.

Authors:  Yang Yang; M Elizabeth Halloran; Yanjun Chen; Eben Kenah
Journal:  Biometrics       Date:  2014-04-25       Impact factor: 2.571

2.  Assessing treatment effects with surrogate survival outcomes using an internal validation subsample.

Authors:  Jarcy Zee; Sharon X Xie
Journal:  Clin Trials       Date:  2015-05-14       Impact factor: 2.486

3.  Validation data-based adjustments for outcome misclassification in logistic regression: an illustration.

Authors:  Robert H Lyles; Li Tang; Hillary M Superak; Caroline C King; David D Celentano; Yungtai Lo; Jack D Sobel
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

4.  An approximate quasi-likelihood approach for error-prone failure time outcomes and exposures.

Authors:  Lillian A Boe; Lesley F Tinker; Pamela A Shaw
Journal:  Stat Med       Date:  2021-06-22       Impact factor: 2.497

5.  Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample.

Authors:  Jarcy Zee; Sharon X Xie
Journal:  Biometrics       Date:  2015-04-27       Impact factor: 2.571

6.  Use of administrative data to increase the practicality of clinical trials: Insights from the Women's Health Initiative.

Authors:  Garnet L Anderson; Carolyn J Burns; Joseph Larsen; Pamela A Shaw
Journal:  Clin Trials       Date:  2016-06-30       Impact factor: 2.486

7.  Parameter estimation in Cox models with missing failure indicators and the OPPERA study.

Authors:  Naomi C Brownstein; Jianwen Cai; Gary D Slade; Eric Bair
Journal:  Stat Med       Date:  2015-08-04       Impact factor: 2.373

8.  Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEX.

Authors:  Eric J Oh; Bryan E Shepherd; Thomas Lumley; Pamela A Shaw
Journal:  Stat Med       Date:  2017-11-29       Impact factor: 2.373

Review 9.  Statistical modeling of Huntington disease onset.

Authors:  Tanya P Garcia; Karen Marder; Yuanjia Wang
Journal:  Handb Clin Neurol       Date:  2017

10.  Raking and regression calibration: Methods to address bias from correlated covariate and time-to-event error.

Authors:  Eric J Oh; Bryan E Shepherd; Thomas Lumley; Pamela A Shaw
Journal:  Stat Med       Date:  2020-11-02       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.